CD19 CAR-T

BIOLOGICAL6 trials

Conditions

Adult B Acute Lymphoblastic LeukemiaB-ALLB-cell Acute Lymphocytic LeukemiaChildhood Acute Lymphoblastic LeukemiaNon-hodgkin's LymphomaRefractory Indolent Adult Non-Hodgkin Lymphoma

Early Phase 1

CAR-T Cells in Treating Patients With Relapsed or Refractory NHL

NCT04626739

Hebei Senlang Biotechnology Inc., Ltd.Refractory Indolent Adult Non-Hodgkin Lymphoma

Start: 2020-04-01End: 2023-03-30Target: 100Updated: 2020-11-13

CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia

NCT04626765

Hebei Senlang Biotechnology Inc., Ltd.Childhood Acute Lymphoblastic Leukemia

Start: 2020-04-01End: 2023-05-30Target: 50Updated: 2020-11-13

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

NCT04626726

Hebei Senlang Biotechnology Inc., Ltd.Adult B Acute Lymphoblastic Leukemia

Start: 2020-04-01End: 2023-05-30Target: 50Updated: 2020-11-13

Phase 1

CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.

NCT03263208

Henan Cancer HospitalB-cell Acute Lymphocytic Leukemia

Start: 2017-08-16End: 2019-07-31Target: 20Updated: 2017-10-20

Unknown Phase

Clinical Trial of SL1904B CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

NCT04447547

Hebei Senlang Biotechnology Inc., Ltd.Non-hodgkin's Lymphoma

Start: 2020-06-30End: 2022-12-30Target: 20Updated: 2020-09-29

Safety and Efficacy Study of SL1904B CAR-T Cells for Relapsed or Refractory B-Cell Acute Lymphocyte Leukemia

NCT04546893

Hebei Senlang Biotechnology Inc., Ltd.B-ALL

Start: 2020-09-01End: 2022-12-01Target: 20Updated: 2020-09-14

Related Papers

Safety and Efficacy of CD 19 CAR T Cells (S1904) in Patients with RR B-ALL: A Pooled Analysis of Two Early-Phase Trials

Blood2024-11-05

Comparative Analysis of Immune Effector Cell-Associated Hematotoxicity (ICAHT) and Infection Incidence Following CD19-Targeted CAR-T Therapy Versus CD7-Targeted CAR-T Therapy

Blood2023-11-021 citations

The Efficacy of Chidamide Maintenance Therapy after CAR-T Therapy for Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia

Blood2022-11-154 citations

Evolution and Proliferation of CD7 CAR-T Cells Compared to CD19 CAR-T Cells Therapies for Acute Leukemia

Blood2021-11-053 citations